Trial
Match
:Beta
Trials
Patients
Matches
Settings
Manage Trials
Manage Patients
Patients
Select Trial
Denosumab for Type 1 Diabetes (NCT06524960)
A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG) (NCT06211764)
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents (NCT06120491)
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT [PIVOT-006] (NCT06111235)
Prospective Database Registry Study of Scoliosis in Children With Cerebral Palsy (NCT00680264)
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) (NCT04793958)
Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy (NCT05206513)
Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD (NCT06267560)
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03) (NCT06797635)
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC [CORE-008] (NCT06567743)
Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA Nephropathy (NCT05834738)
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer (NCT06319820)
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004) (NCT06136650)
DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC (NCT06364917)
A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease (NCT06522997)
Horizon Adaptive Platform Trial Evaluating Therapies in RRMM (NCT06171685)
Select Patient
Donna Harris
Donald Lopez
Jessica Smith
Joshua Gonzalez
FHIR Patient JSON
{ "patient": {"resourceType":"Patient","id":"NCT06524960-3","extension":[{"url":"http://hl7.org/fhir/StructureDefinition/us-core-race","valueCodeableConcept":{"coding":[{"system":"http://hl7.org/fhir/v3/Race","code":"2106-3","display":"White"}]}},{"url":"http://hl7.org/fhir/StructureDefinition/us-core-ethnicity","valueCodeableConcept":{"coding":[{"system":"http://hl7.org/fhir/v3/Ethnicity","code":"2186-5","display":"Non-Hispanic"}]}}],"identifier":[{"use":"usual","system":"http://example.org/patients","value":"123456789"}],"name":[{"use":"official","family":"Harris","given":["Donna"]}],"telecom":[{"system":"phone","value":"555-123-4567","use":"home"},{"system":"email","value":"donna.harris@example.com","use":"home"}],"gender":"female","birthDate":"1985-06-15","address":[{"use":"home","line":["123 Elm Street"],"city":"Springfield","state":"IL","postalCode":"62701","country":"USA"}],"maritalStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/v3-MaritalStatus","code":"M","display":"Married"}]},"communication":[{"language":{"coding":[{"system":"urn:ietf:bcp:47","code":"en","display":"English"}]},"preferred":true}]}, "fhirResources": [{"resourceType":"Condition","id":"NCT06524960-3-0","clinicalStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-clinical","code":"active","display":"Active"}]},"verificationStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-ver-status","code":"confirmed","display":"Confirmed"}]},"code":{"coding":[{"system":"http://snomed.info/sct","code":"46635009","display":"Type 1 diabetes mellitus"}]},"subject":{"reference":"Patient/NCT06524960-3"},"onsetDateTime":"2010-05-01"},{"resourceType":"Observation","id":"NCT06524960-3-1","status":"final","code":{"coding":[{"system":"http://loinc.org","code":"2028-9","display":"C-peptide [Mass/volume] in Serum or Plasma"}]},"subject":{"reference":"Patient/NCT06524960-3"},"effectiveDateTime":"2023-09-15","valueQuantity":{"value":0.3,"unit":"nmol/L","system":"http://unitsofmeasure.org","code":"nmol/L"}},{"resourceType":"Observation","id":"NCT06524960-3-2","status":"final","code":{"coding":[{"system":"http://loinc.org","code":"4548-4","display":"Hemoglobin A1c/Hemoglobin.total in Blood"}]},"subject":{"reference":"Patient/NCT06524960-3"},"effectiveDateTime":"2023-09-15","valueQuantity":{"value":8.7,"unit":"%","system":"http://unitsofmeasure.org","code":"%"}},{"resourceType":"MedicationStatement","id":"NCT06524960-3-3","status":"active","subject":{"reference":"Patient/NCT06524960-3"},"effectivePeriod":{"start":"2010-05-01"}} ], "patientNote": "Patient is a 38-year-old female with a history of type 1 diabetes diagnosed approximately 3 years ago. She has been managing her condition with insulin therapy and reports generally stable blood glucose levels, although she occasionally experiences mild hypoglycemic episodes. Her recent HbA1c was measured at 8.7%, indicating suboptimal glycemic control. Patient has a BMI of 29 kg/m2, which is within the acceptable range for her height and weight. She denies any recent episodes of severe hypoglycemia or diabetic ketoacidosis. Patient is currently taking insulin and has not used any other diabetes medications in the past three months. She reports feeling fatigued and has noticed some difficulty concentrating, which she attributes to her fluctuating blood sugar levels. Her C-peptide levels were measured at 0.3 nmol/L, suggesting some residual beta cell function. Patient is married and lives with her husband and two children. She is fluent in English and prefers to communicate in this language during medical consultations. Overall, she is motivated to improve her diabetes management and is interested in exploring new treatment options.", "grade": "Disqualified" }
Patient Note
Patient is a 38-year-old female with a history of type 1 diabetes diagnosed approximately 3 years ago. She has been managing her condition with insulin therapy and reports generally stable blood glucose levels, although she occasionally experiences mild hypoglycemic episodes. Her recent HbA1c was measured at 8.7%, indicating suboptimal glycemic control. Patient has a BMI of 29 kg/m2, which is within the acceptable range for her height and weight. She denies any recent episodes of severe hypoglycemia or diabetic ketoacidosis. Patient is currently taking insulin and has not used any other diabetes medications in the past three months. She reports feeling fatigued and has noticed some difficulty concentrating, which she attributes to her fluctuating blood sugar levels. Her C-peptide levels were measured at 0.3 nmol/L, suggesting some residual beta cell function. Patient is married and lives with her husband and two children. She is fluent in English and prefers to communicate in this language during medical consultations. Overall, she is motivated to improve her diabetes management and is interested in exploring new treatment options.
Save Changes
An unhandled error has occurred.
Reload
🗙